Trial Profile

Evaluate Efficacy and Safety of DKP21102_B Added on to DKP21102_A Compared With DKP21102_A in Mixed Dyslipidemia Patients

Status: Withdrawn prior to enrolment

Phase of Trial: Phase III

Latest Information Update: 28 Oct 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs DKP-21102 (Primary)
Indications Dyslipidaemias
Focus Registrational; Therapeutic Use
Sponsors Dongkwang Pharm

Most Recent Events

24 Oct 2024 Planned initiation date changed from 1 Jul 2024 to 1 Jan 2025.
24 Oct 2024 Status changed from not yet recruiting to withdrawn prior to enrolment.
18 Feb 2024 Planned End Date changed from 1 Jun 2025 to 1 Dec 2027.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com